How to Take Glimepiride/Pioglitazone
The starting dosage of this combination drug is 30 mg / 2 mg once a day. This is the lowest concentration of the medicine which may be prescribed at the onset of the treatment. In the later stages, the dosage may increase to 30 mg / 4 mg a day. In case the blood sugar level is not controlled with the administration of either of these dosages, people may be recommended higher concentration of 45 mg / 8 mg on a daily basis. However, the alterations in the dosages of this medicine may be suggested only after a definite interval of time. here are many other factors as well that may impact the initial and later concentrations of the drug suggested to the patients. These factors may include intensity of diabetes, other medications, and progression of other medical conditions, age, weight. Further, it is a blunder to abruptly stop the dosage of the drug on observing signs of improvements without the consent of the doctor. Ideally, on conditions of remarkable improvements, the concentration of the drug is gradually decreased and then stopped instead of suddenly stopping its intake. Moreover, one should make efforts to consume the drug on the same time of every day so as to avoid chances of missed dosages. Buy Now Glimepiride/Pioglitazone
|
|
Glimepiride/Pioglitazone General informationGlimepiride/Pioglitazone is a combination drug prescribed for the treatment of type 2 diabetes. It essentially works towards alleviating the level of blood sugar by stimulating the pancreas to release adequate insulin. In addition, the daily consumption of the drug enhances the level of insulin sensitivity in the body. How to Buy Glimepiride/PioglitazoneGlimepiride/Pioglitazone is generic Duetact. Glimepiride/Pioglitazone falls in the category of Thiazolidinedione antidiabetics. They are used in treating diabetes type2. There are a few precautionary measures that must be followed by patients of diabetes especially if the patient also has heart problems. Conditions Glimepiride/Pioglitazone TreatsThe drug Glimepiride/Pioglitazone has been licensed for the treatment of type 2 diabetes. It is conceived from a strong formulation of two drugs- Glimepiride and Metformin. It is essentially used for controlling the level of blood sugar particularly among those patients who do not take to insulin injections.
|
|
